Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
22 mai 2024 08h30 HE
|
Optimi Health Corp.
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
Healis Therapeutics Announces Supply Agreement with CKD Bio to develop CKDB-501 for neuropsychiatric indications
02 janv. 2024 08h00 HE
|
Healis Therapeutics
NEWPORT BEACH, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Healis Therapeutics, a privately held biotechnology company, today announced it has entered into a supply agreement with CKD Bio Corporation...
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
07 déc. 2023 07h30 HE
|
Optimi Health Corp.
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
02 nov. 2023 07h30 HE
|
Kura Oncology, Inc.
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Worksport Signs Long Term Agreement with Customer for US Factory Product and Expects US$16,000,000 in Annual Sales, Marking Significant Growth and Demand at NY Factory.
19 sept. 2023 07h00 HE
|
Worksport Ltd
West Seneca, N.Y., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Worksport Ltd. (“Worksport” or the “Company”) (Nasdaq: WKSP; WKSPW) announces it has secured a long-term supply agreement with an established,...
BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
12 sept. 2023 09h00 HE
|
BioRestorative Therapies, Inc
--BioRestorative to Leverage its Core Competencies in Cell Biology and Manufacturing to Supply Biologics for Cosmetic Applications in Strategic Agreement --Agreement Represents Initial Venture into...
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
15 juin 2023 09h40 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
Blue Star Foods Signs $1 Million Supply Agreement with Bloomin’ Brands
01 juin 2023 08h30 HE
|
Blue Star Foods Corp.
Supplying Pasteurized Crab Meat for its Outback Steakhouse Miami, FL, June 01, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an...
Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development
04 mai 2023 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), today announced that it has entered into a...
Blue Star Foods Ramps Shipments to Just Food For Dogs Under its Supply Agreement for Up to $4 Million Annually
26 avr. 2023 08h00 HE
|
Blue Star Foods Corp.
New Category Relationship Progressing as Expected Miami, FL, April 26, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an...